Setting a higher health care management standard with InnovaCare Health

A critical aspect of each person’s well-being is their health care plan. The management of that health care plan, however, can be quite the tiresome task. To aid with this task the company InnovaCare Health can offer services that make managing your health care plan a whole lot more simple and easy. InnovaCare Health is a North American company with their headquarters office located in Fort Lee, New Jersey. They provide a good variety of different health care models for affordable prices.

InnovaCare Health puts extra effort into maintaining a good quality service that puts emphasis on communication between the providers of health care and their clients. InnovaCare Health strictly believes that their patients come first and so for that reason the company has set a goal to establish a new higher standard of how health care is being managed. To reach their goal and to provide the best quality offers possible, InnovaCare Heal have assembled teams of health care experts that are capable of realizing that ambition. Together they outline a clear picture of the kind of services InnovaCare Health can offer to their clients and how to best make the communication between all involved parties as easy as possible. Learn more about the company at Businesswire.com

  1. Richard Shinto is the current President and Chief Executive Officer of InnovaCare Health. He was offered the position in 2012 after the previous company he was a part of saw sold. Dr. Richard Shinto has a rich clinical experience of more than 20 years. Dr. Shinto also has a lot of experience in the operational health care field. He earned his Bachelor’s degree from the University of California at Irvine. His medical degree was issued from the State University of New York at Stony Brook. Dr. Richard Shinto has also greatly contributed to his articles on clinical medicine as well as healthcare management. He has given some lectures at different medical schools to help educate and inspire future medical professionals.

Presently, the Chief Administrative Officer of InnovaCare Health is Penelope Kokkinides. She returned to the company in the June of 2015. Penelope Kokkinides worked together with Dr. Richard Shinto at their former workplace Aveta as Chief Operating Office. She also has more than 20 years of experience in the field of health care management. Penelope Kokkinides earned a Bachelor’s degree as well as master’s degree from Columbia University School of Public Health.

Oncotarget – The Journal of Research

Oncotarget is a medical journal published on a weekly basis with an open and free access. Oncotarget publications cover research and study of all fields of oncology. Oncotarget was established in the year 2010. Oncotarget has a fifty member editorial board. The editor-in-chief is Professor Mikhail Blagosklonny.

Oncotarget’s sole mission is to make scientific results widely available and rapidly accessible. Oncotarget aims to maximize the impact of research via an insightful review. Oncotarget has produced several issues, each issue is easily and readily accessible online. Follow Oncotarget on Twitter.

Oncotarget has an excellent editorial board comprising of fifty highly knowledgeable and successful professionals. Among them are Andrei V. Gudkov, Mikhail V. Blagosklonny, Cory Abate-Shen, Frederick Alt, Dario Altieri, Dafna Bar-Sagi, Jiri Bartek, Stephen Baylin, Joseph R. Bertino, Mina J. Bissell, Bruce Blazar, Kenneth Cowan, Carlo M. Croce, Chi Van Dang, Ronald A. DePinho, Brian J. Druker, Wafik S.El-Deiry, Michael A. Dyer, Andrew Feinberg, Dean W. Felsher, Antonio Giordano, Candace S Johnson, William G. Kaelin, Jr, Michael Karin, Scott E. Kern, Guido Kroemer, John S. Lazo, Arnold Levine, Michael P. Lisanti.

Oncotarget is a reliable publication that adheres strictly with the COPE Code of Conduct Best Practices Guidelines for Journal Editors and Code of Conduct for Journal Publishers. All editors of the medical journal also follow the best practice guidelines on ethical behavior and ICMJE’s Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals.

Oncotarget is a medical journal that prides itself on accuracy and scientific merit of all data contained in each of their publications. Download output styles at Endnote.com

Dr. Shiva Vashista; Excellence in Neurology

Results of a new clinical trial has provided evidence that a high-dose immunosuppressive therapy followed by a person’s transplant of blood-forming stem cells may induce a sustained cutback of relapsing-remitting multiple sclerosis. This is an autoimmune illness where the immune systems attack the CNS (Central Nervous System). After five years of treatment with the high-dose immunosuppressive therapy alongside hematopoietic cell transplant (HDIT/HCT), 69 percent of the participants in the trial survived without experiencing a relapse of MS signs or new brain lesion, or experiencing any progression of disability. It is also worth noting that the participants didn’t take any MS medications once they received HDIT/HCT. The five-year results suggest that this kind of treatment is promising in the induction of long-term unremitting diminutions of poor-prognosis relapsing-remitting MS.

The National Institute of Allergy and Infectious Diseases (NIAID) is the organization that sponsored the trial which was known as HALT-MS. It was conducted by ITN (Immune Tolerance Network) which is funded by NIAID. The researchers then published results based on three years of the study in 2014. These new findings suggest that one-time treatment with High-dose immunosuppressive therapy and Hematopoietic cell transplant is more effective than long-term handling using the best current medications for individuals with a particular strain of MS.

One of the most recognized authorities in neurology is one Dr. Shiva Gopal Vasishta. The Voorhees, New Jersey-based neurologist, has close affiliations with the Kennedy University Hospital. Dr. Shiva Gopal Vashista attended the Government Medical College from where he attained his medical degree. He is a well-seasoned practitioner with an over 28 years of experience in his career.

Dr. Shiva Gopal Vasishta boasts to be among the 34 doctors in Kennedy University Hospital who are entirely specialized in Neurology. Dr. Shiva Gopal Vashista has a license for operation in New Jersey and is also a participant in the Medicare program.